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Abstract
Background: The present investigation was designed to elucidate the use of dynamic contrast enhanced perfusion 
MR imaging (DCE pMRI) in characterizing hyperemia, including microvessel changes, and to examine whether DCE 
pMRI can predict benign or malignant hyperemia.
Methods: Sprague-Dawley rats underwent middle cerebral artery occlusion (MCAO) by intraluminal suture placement. 
All rats were randomized to 4 groups: MCAO for 0.5 hours followed by saline treatment (10 ml/kg; group 1); MCAO for 3 
hours followed by treatment with saline (group 2) or urokinase (25000 IU/kg; group 3); and MCAO for 6 hours followed 
by urokinase treatment (group 4). Relative cerebral blood volume (rCBV) and relative maximum slope of increase of the 
signal intensity time curve (rMSI) were quantitatively analyzed from MRI. Microvessel diameter and blood-brain barrier 
disruption obtained by laser scanning confocal microscopy (LSCM) as well as transmission electron microscopy (TEM) 
were obtained for correlative study.
Results: Benign hyperemia was noticed only in group 1; malignant hyperemia was seen in group 3. Although the rCBV 
of malignant hyperemia was slightly higher than in benign hyperemia (P > 0.05), the rMSI, on the other hand, was 
significantly lower (P < 0.05). Fluoro-isothiocyanate dextran (FITC-dextran) extravasations, marked glial end-foot 
process swelling, and significant vasodilatation were seen in malignant hyperemia, while no or mild leakage of FITC-
dextran and slight glial end-foot process swelling occurred in benign hyperemia.
Conclusion: Our findings indicate that DCE pMRI can characterize post-ischemic hyperemia and correlates well with 
microvascular damage.
Background
Animal and human studies have demonstrated that post-
ischemic hyperperfusion may occur in acute cerebral
ischemia following vessel recanalization [1-7]. Sequential
experimental positron emission tomography (PET)
revealed three types of hyperperfusion following tran-
sient middle cerebral artery occlusion (MCAO) in cats
[2]. Type 1 showed immediate hyperperfusion lasting for
the whole observation period and covering a large part of
the ischemic territory. In type 2, hyperperfusion was
transient, and was often followed by hypoperfusion in
some parts of the previously hyperperfused regions. In
type 3, hyperperfused regions grew progressively(Table
1)[2]. When regions undergo transient early hyperperfu-
sion or progressive hyperperfusion over time, they often
have small infarctions, while regions with continued
hyperperfusion have particularly poor outcomes [2,3].
Clinical study, on the other hand, has indicated no signif-
icant differences in the degree of clinical improvement in
patients with regions of hyperperfusion versus those
without [4]. The variance between experiment and clini-
cal findings indicates that the underlying mechanism of
hyperperfusion after reperfusion remains unknown. Graf.
R et al. hypothesis that type 1 hyperemia was referred to
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Apart from the difference in time course and final
infarction, there is no further knowledge of the differ-
ences between kinds of hyperperfusion, including
microvessel changes. Furthermore, hyperperfusion data
were mainly obtained by PET, there is insufficient data on
the use of magnetic resonance contrast agent (MRCA)-
enhanced MR imaging (MRI) with GD-DTPA to charac-
terize hyperemia, though it is often used to evaluate BBB
opening in stroke [2-5,8-10]. In addition, hyperperfusion,
according to its strict definition, is an increase in cerebral
blood flow (CBF). However, this definition is generally
impractical, especially in human studies, because of the
lack of pre-stroke CBF measurements, whereas hypere-
mia, defined as increase in cerebral blood volume, is
more practical and often occurs during hyperperfusion
[4,11]. We designed a reperfusion model with varying
occlusion timesand different type of treatment to investi-
gate the underlying mechanisms of the different kinds of
hyperemia in rats following reperfusion, including their
microvessel changes, to find out whether duration of
ischemia or additional thrombolysis could influence the
type of hyperemia, and to examine whether dynamic con-
trast enhanced perfusion MRI (DCE pMRI) can predict
different hyperemia types [11-17].
Methods
Animal Model and Protocol
The experimental protocol was approved by the Institu-
tional Animal Care and Use Committee at the Affiliated
Sixth Hospital of Shanghai Jiaotong University. Focal
c e r e b r a l  is c h e m ia  was  i n t r od u c ed  i n  3 3  m a l e  S p r a gu e -
Dawley rats (250 to 300 g) using an intraluminal suture
occlusion model. Briefly, after the rat was anesthetized
using 5 mg/kg ketamine chloride, MCAO was achieved
by introducing a 4-0 paint-coated filament via the exter-
nal carotid artery into the distal common carotid artery.
The filament was then advanced via internal carotid
artery until a faint resistance was felt (about 20 mm from
the carotid bifurcation). After 0.5 hours, 3 hours, or 6
hours of occlusion, rats were treated with saline (10 ml/
kg) or urokinase (25000 IU/kg, Shanghai Zhongxi Phar-
maceuticals, China) intravenously over 1 hour immedi-
ately after suture withdrawal.
During the operation, rat rectal temperature was main-
tained at 37°C using a heating pad. All rats were random-
ized to 4 groups: the left middle cerebral artery (MCA)
was occluded for 0.5 hours followed by saline treatment
(10 ml/kg) after suture withdrawal (group 1, n = 8); the
left MCA was occluded for 3 hours followed by treatment
with saline (10 ml/kg; group 2, n = 8) or urokinase (25000
IU/kg; group 3, n = 8) after suture withdrawal; and the left
MCA was occluded for 6 hours followed by urokinase
treatment (25000 IU/kg; group 4, n = 9). MRI was per-
formed 10 minutes before reperfusion and both 3 hours
and 10 days following vessel reperfusion.
MRI
MRI was performed using a GE Signa 1.5 T system with a
3-inch surface coil. T1- and T2-weighted images were
obtained using a 3-mm thick section and 0.5 mm inter-
section space with a 256 × 160 matrix. Diffusion-
weighted images (DWI) were acquired with 8000 ms rep-
etition time, 97.8 ms echo time, and b value of 1000 s/
mm2. DCE pMRI was obtained by a gradient-echo planar
sequence during the first pass of a standard bolus of gad-
opentetate dimeglumine (Gd-DTPA), 0.2 mmol/kg
(about 0.5 mL), which was injected through the femoral
vein after the first 5 baseline scans. Five images were
acquired with 50 repetitions, which resulted in a total
acquisition time of 56 seconds. Repetition time was 1000
ms and echo time was 34.7 ms. To avoid image deformity
and improve the signal-to-noise ratio, both DWI and
DCE pMRI were acquired with a matrix 64 × 64, field of
view (FOV) 5 × 5, thickness 3 mm, and intersection space
0.5 mm. Post-contrast axial T1-weighted images were
acquired following the acquisition of DCE pMRI data.
To quantitatively analyze DCE pMRI, regions of inter-
est (ROIs; 2 mm2) were hand-drawn to cover the parietal
cortex and striatum, both of which are usually affected in
the MCAO model, as well as homologous areas on the
Table 1: Classification of three types of hypermia described by Graf R, et al.
Classification Manifestation Quality
Type 1 showed immediate hyperperfusion lasting 
for the whole observation period and 
covering a large part of the ischemic 
territory
malignant hyperemia
Type 2 hyperperfusion was transient, and was 
often followed by hypoperfusion in some 
parts of the previously hyperperfused 
regions
benign hyperemia
Type 3 hyperperfused regions grew progressively benign hyperemiaLu et al. BMC Neurology 2010, 10:24
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contralateral side. A signal intensity time curve was
obtained over each ROI. The cerebral blood volume and
maximum slope of increase of the signal intensity time
curve (which indicates the velocity of signal intensity
return to baseline) were calculated automatically at the
workstation (SUN Microsoft Ultra 60) using commer-
cially available post-processing software (Functool
2.5.36d, GE Medical Systems). The relative cerebral blood
volume (rCBV) and the relative maximum slope of
increase (rMSI) were produced using the following for-
mulas: rCBV = CBV on the ipsilateral side/CBV on the
contralateral side; and rMSI = MSI on the ipsilateral side/
MSI on the contralateral side. An rCBV increase of more
than 20% compared with the value on the contralateral
n o r m a l  s i d e  w a s  r e g a r d e d  a s  h y p e r e m i a ,  a s  d e s c r i b e d
elsewhere, and the results were divided into 5 types
according to the appearance of perfusion changes: nor-
mal perfusion (N), early hyperemia, late normal perfu-
sion (I), early normal perfusion, late hyperemia (II),
persistent hyperemia (III), and persistent hypoperfusion
(IV) [5].
Light Microscopy and Transmission Electron Microscopy 
(TEM) Studies
Two animals randomly selected from each group were
killed after 3 hours and 10 days of recanalization. The tis-
sues where the rCBV and rMSI had been monitored were
block-dissected, fixed brain tissues were serially sec-
tioned axially at 500 μm, and then were rinsed, osmi-
cated, dehydrated, and embedded in Epon-Araldite
plastic (Shanghai Colophony Company, Shanghai,
China). Ultra-thin sections of 90 nm were then cut from
the same blocks and stained with uranyl acetate and lead
citrate for transmission electron microscopy (TEM) anal-
ysis.
Our targets were brain capillaries, so ultra-thin sections
were first examined at low power to find capillaries with
walls sectioned at 90° to the long axis of their lumina.
Photomontages of brain capillaries were then made and
each animal had 2 sections with 10 photomontages. Mor-
phometric analysis was performed using the LEICA
Qwin imaging analysis system (Germany). Measurements
were made of luminal surface area (LSA) and pericapil-
lary glial sheath surface area (PGSA) as described else-
where [7].
The remaining parts of the fixed brain tissue were sec-
tioned at 5 μm and stained with hematoxylin and eosin
for light microscopy. Volume of cerebral infarction was
measured using the LEICA Qwin imaging analysis system
as well. Each H& E stained section was evaluated at 10 ×
magnification, the area of infarction were calculated on
H&E stained section by tracing the area on computer
screen, and the volume were determined by integrating
the appropriate area with the section interval thickness.
Laser Scanning Confocal Microscopy (LSCM) Examination
Ten days following vessel reperfusion, fluoro-isothiocya-
nate dextran (FITC-dextran, SIGMA, USA; 1 ml of 50
mg/ml preparation) was administered intravenously to 2
animals in each group. After FITC-dextran circulated for
1 minute, the brains were rapidly removed and placed in
4% paraformaldehyde at 4°C for 24 hours. Axial sections
(50 μm thick) were cut on a vibration microtome, and the
sections corresponding to MRI were analyzed by laser
scanning confocal microscopy (LSCM; LSM510-Zeiss,
Germany). The green fluorochromes in each section were
excited by a laser beam at 488 nm.
Using tissue samples from each rat, 10 sections at 1 mm
intervals were screened under 5× objective lens to find
the areas corresponding to where rCBV and rMSI had
been monitored. Under 10 × magnifications, areas of
interest in the infarct region as well as the homologous
areas on the contralateral side were scanned with a 1024
× 1024 matrix in the x-y direction, along the z-axis with a
1 μm step size. After scanning, three-dimensional recon-
structions were employed to produce microvascular
architecture that was labeled by FITC-dextran. The diam-
eters of microvessels in the infarct zone as well as in
homologous contralateral areas were calculated.
Statistical Analysis
A statistical package (SPSS, version 13.0 for windows;
SPSS, Ill, USA) was used for statistical analysis. Compari-
sons of measured rCBV, rMSI, and diameter of microves-
sels between different groups were performed by one-
way ANOVA or paired-samples t-test. Values are given as
mean ± SD, and P < 0.05 was accepted as significant.
Results
Two rats in group 3 and three rats in group 4 died owing
to large infarctions before the end of the experiment,
these 5 rats were eliminated from the study. Ten days
after reperfusion, the initial hyperintense areas on DWI
returned to normal in 3 of 8 rats in group 1, and remained
hyperintense in the other groups. In both parietal cortex
and striatum, rCBV reduced significantly in groups 2, 3,
and 4 before reperfusion compared with that in group 1,
and only mild reduction of rCBV was noticed in group 1
before reperfusion compared to the unaffected hemi-
sphere. After reperfusion, hyperemia was visualized only
in groups 1 and 3, while hypo- or normal perfusion was
found in the other groups (Figure 1A, Table 2). Type I
hyperemia was noticed in the infarct region in group 1,
a n d  t yp e  I I  a n d  I I I  w e r e  s e e n  i n  t h e  i n f a r c t  r e g i o n  i n
group 3. Although the degree of rCBV in group 3 was
slightly higher than that in group 1, no significant differ-
ence was found between them (P > 0.05). The rMSI, on
the other hand, was significantly lower in group 3 com-
pared with that in group 1 (P < 0.05) (Figure 1B). MeanLu et al. BMC Neurology 2010, 10:24
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infarct volumes was 20 mm3 ± 11 in group 1, 118 mm3 ±
32 in group 2, 132 mm3 ± 49 in group 3 and 287 mm3 ± 71
in group 4, no hemorrhagic transformation was found in
any group.
According to LSCM, all areas showing type II and type
III hyperemia demonstrated FITC-dextran extravasations
a s  w e l l  a s  s i g n i f i c a n t  v a s o d i l a t a t i o n ,  w h i l e  n o  o r  m i l d
leakage of FITC-dextran and slight dilation of microves-
s e l s  o c c u r r e d  i n  t ype  I  h ype r e m i a  ( P  <  0 . 0 5 ;  F i g u r e  2 ,
Table 3).
Three hours after reperfusion, group 1 showed mild
astroglial end-foot process edema, and capillaries had an
irregular luminal surface. Ten days after reperfusion, the
end-foot process edema decreased slightly, and LSA
decreased from 6.4 μm2 to 2.1 μm2 with no change in
PGSA (Table 4). In group 3, severe astroglial end-foot
process edema was found even 10 days after reperfusion,
and LSA decreased from 17.4 μm2 to 6.6 μm2; further-
more, PGSA increased steadily (Figures 3). According to
pathology and changes in infarct volume, type I hypere-
mia was referred to benign hyperemia, while type type II
and III hyperemia were malignant.
Discussion
Our study provides unique insight into post-ischemic
hyperemia. We found that post-ischemic hyperemia
mainly occurred in group 1 and group 3, while hypo- or
normal perfusion was found in the other groups. Further-
more, benign hyperemia was noticed in rats after 0.5
hours of MCAO following recanalization, but malignant
hyperemia occurred after 3 hours of MCAO with addi-
tional thrombolysis. These results indicate that longer
times of ischemia with additional thrombolysis may be
associated with malignant hyperemia, and hyperemia
does not develop after prolonged ischemia because of a
greater tendency for lack of reflow.
Our data suggest that the different kinds of post-isch-
emic reperfusion resulted from different microvessel
conditions. Benign hyperemia (i.e. reactive hyperemia)
mainly occurred after transient ischemia and might be
caused by neurogenic-mediated vessel dilatation [18].
The cerebral resistance vessel (e.g. arteriole) was unable
to constrict during reperfusion, but the integrity of
microvessels remained, and when the neurogenic reac-
tion ceased, the microvessels recovered their normal con-
dition, so no hyperemia was found in the later stage. After
Table 2: Dynamic contrast enhanced perfusion MRI changes before and after reperfusion
Group n rCBV(%) rMSI(%)
mean ± SD mean ± SD
Group 1
Before 8 86.0 ± 8.2* 110.6 ± 12.4
3 h 8 141.5 ± 22.3 80.7 ± 19.1
10 d 8 102.8 ± 11.3 109.0 ± 6.2**
Group 2
Before 14 46.2 ± 16.9* 69.7 ± 30.1
3 h 8 88.3 ± 13.8 74.8 ± 19.9
10 d 8 78.3 ± 9.3 75.0 ± 19.5
Group 3
Before 14 46.2 ± 16.9* 69.7 ± 30.1
3 h 6 127.8 ± 13.6 82.5 ± 30.7
10 d 6 173.5 ± 45.2 51.8 ± 10.9**
Group 4
Before 6 23.6 ± 16.8* 59.4 ± 27.5
3 h 6 103.4 ± 26.6 64.1 ± 28.9
10 d 6 80.0 ± 28.6 76.0 ± 24.3
rCBV = relative cerebral blood volume; rMSI = relative maximum slope of increase; before = before reperfusion; 3 h = three hours after 
reperfusion; 10 d = ten days after reperfusion.
*Significant difference (P < 0.5) among the different groups before reperfusion.
**Significant difference (P < 0.5) between group 1 and group 3 ten days after reperfusion.Lu et al. BMC Neurology 2010, 10:24
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Figure 1 MR images and signal-intensity time curves in different types of hyperemia. A, Slight hyperintensity of the left hemisphere was found 
on T2-weighted imaging and DWI, respectively, with remarkable enhancement on contrast-enhanced T1-weighted imaging (arrow head) in G1-1 and 
G3-1. Ten days after reperfusion, signal intensity returned to normal on T2-weighted imaging and DWI, and no enhancement was found on contrast-
enhanced T1-weighted imaging in G1-2. However, the hyperintensity remained on T2-weighted imaging and DWI, with continuous enhancement 
on contrast-enhanced T1-weighted imaging in G3-2 (arrow head). B, Signal intensity plotted against time for the infarct region (dots in G1-1, triangles 
in G3-2) and homologous areas on the contralateral side (squares). The lines represent the curves derived by using the DCE pMRI. The return to base-
line is lower in G3-2 than in G1-1, suggesting high permeability of the BBB. G1-1 = three hours after reperfusion of rats in group 1; G1-2 = ten days after 
reperfusion of rats in group 1; G3-1 = three hours after reperfusion of rats in group 3; G3-2 = ten days after reperfusion of rats in group 3; T1WI C+ = 
contrast-enhanced T1-weighted imaging; Con l = contralateral side; b hyp = benign hyperemia; m hyp = malignant hyperemia.Lu et al. BMC Neurology 2010, 10:24
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a longer MCAO, polymorph nuclear leukocytes adhered
and fibrin formations and platelet-fibrin aggregated,
decreasing focal reflow in both capillaries and postcapil-
lary venules after suture withdrawal from MCA, although
the microvessels dilated [1]. This would explain why there
was no hyperemia in group 2. After thrombolytic treat-
ment, microvessels were fully recanalized, which caused
the initial hyperemia in group 3, but the release of vasodi-
lating substances might contribute to persistent vessel
dilatation and the later stage of hyperemia in group 3
[19]. However, three hours after MCAO, the primary
microvessel permeability barrier was lost, and swollen
endothelial cells and astrocytes prevented microvessel
recovery. Persistent and prolonged hyperemia could
cause additional damage by inducing edema via leaking
vascular endothelium, resulting in malignant hyperemia.
After much longer ischemia (i.e. 6-hour MCAO), extrin-
sic compression from edema and endothelial cell swelling
compressed the lumen of the microvessels, inhibiting
hyperemia; this may be why no hyperemia was found in
group 4.
Post-ischemic hyperemia, defined as more than a 20%
increase in CBV compared with the normal contralateral
side by MRI, has been documented in one previous study
in cats [5]. Although a different kind of hyperemia was
found in that study, all animals only underwent one hour
of MCAO. In our study, rats undergoing varying occlu-
sion times were evaluated following suture withdrawal
with or without thrombolysis, and all three type of hyper-
emia were found, but early hyperemia, late normal perfu-
sion, and persistent hyperemia caused different
outcomes, which differs from the previous study [5]. This
might owe to the longer time of ischemia and longer
interval of MRI than that in the previous study.
Our results also indicated that different types of hyper-
emia had different outcomes. Reperfusion after 0.5 hours
of MCAO, resulting in a brief hyperemia period and a fast
normalization of flow, did not cause gross infarction, or
the final infarct was slight. During longer periods of
MCAO, persistent or late hyperemia was observed, with
an increase in infarct volume and severely swollen glial
end-foot processes and remarkable leakage of FITC-dex-
tran. Forced reperfusion by reopening the MCA could
not salvage already irreversibly damaged tissue, but
caused additional damage, and this effect was aggravated
in paralyzed vessels. Suppression of post-ischemic malig-
nant hyperemia might significantly reduce blood-brain
barrier (BBB) disruption and ischemic edema [1]. In addi-
tion, due to release of vasoactive neuropeptides from
perivascular nerves, blockage of perivascular sensory
nerve fibers or their constituent neuropeptides might
attenuate hyperemia and cerebral edema as well [18]. Pre-
vious experimental and clinical studies have demon-
strated post-ischemic hyperemia using DCE pMRI, and
their data focused on the evaluation of rCBV [4,5]. In our
study, rCBV was higher in malignant hyperemia than in
benign hyperemia, with no significant difference, while
there was a significant difference in rMSI between the
two types. In comparison with LSCM, the decrease in
rMSI coincided with FITC-dextran leakage. DCE pMRI
can monitor the first pass of contrast agent (Gd-DTPA)
through target tissue: a more substantial initial signal
intensity drop indicates higher rCBV, and the delayed
return to baseline often suggests high permeability of
brain tumors [20,21]. Although the volume transfer con-
stant (Ktrans) is a good method to measure the permeabil-
ity of BBB, our results suggest that rMSI, indicating the
velocity of the signal intensity time curve return to base-
line, is a simple index related to BBB permeability, and
Table 3: Diameter of microvessels in different groups 
according to LSCM.
Group diameter (μm) (mean ± SD)
Group 1 16.2 ± 3.5*
Group 2 17.1 ± 2.7
Group 3 46.0 ± 22.4*
Group 4 24.4 ± 6.8
Normal 6.7 ± 1.5
Two animals with 20 sections in each group were calculated.
Normal = the homologous areas on the contralateral side in all 
four groups.
* Significant difference (P < 0.5) between group 1 and group 3 ten 
days after reperfusion.
Figure 2 Cerebral microvessel changes 10 days after reperfusion. 
A, Cerebral microvessel perfusion obtained by FITC-dextran was com-
pared with normal cerebral microvessels in homologous contralateral 
areas. B, No leakage of FITC-dextran and slight dilation of microvessels 
occurred in benign hyperemia. C, The area showing hyperemia on DCE 
pMRI demonstrates FITC-dextran extravasations as well as significant 
vasodilatation in group 3. Bar = 100 μm.Lu et al. BMC Neurology 2010, 10:24
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might be used as an adjunctive parameter to differentiate
benign and malignant hyperemia even if no significant
rCBV difference is evident at a particular time point [21].
Our results also suggest that when patients undergo a
longer time of ischemia, complete recanalization may
result in malignant hyperemia. When this kind of hypere-
mia is demonstrated by DCE pMRI after thrombolysis,
anti-reperfusion injury measurements should be taken to
reduce exacerbation of ischemic edema caused by post-
ischemic hyperemia.
Our study has some limitations. No sham operation
served as a control and quantitative DCE pMRI measure-
ments are not available at our hospital. Therefore, we
used only relative perfusion parameters. Although rCBV
and rMSI do not perfectly represent cerebral blood flow
and the degree of BBB disruption, many hospitals use
them because they are easily calculated using commercial
software. An additional limitation of our study is that we
monitored the CBV of rats after reperfusion only at two
time points. Serial imaging studies performed at more
time points will be required to further characterize the
time course. What's more, the results for LSCM and TEM
are based on only 2 animals of each group.
Conclusion
Our study indicates that benign and malignant post-isch-
emic hyperemia, having different pathogeneses and dif-
ferent outcomes, could be identified using DCE pMRI,
especially when rMSI decreased remarkably. This indi-
cated the BBB disruption, and special management
should be taken to prevent cerebral edema in such cases.
These findings provide a novel measurement which can
be used to characterize post-ischemic hyperemia and
which correlates with microvascular damage.
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